Investor FAQs

Where is ImmunityBio headquartered?
3530 John Hopkins Court
San Diego, CA 92121
Where is ImmunityBio incorporated?

ImmunityBio is incorporated in the State of Delaware. 

Who are the members of ImmunityBio’s executive management team?

Information about ImmunityBio’s management team is available on the Leadership section of this website.

Who are the members of ImmunityBio's Board of Directors?

Information about ImmunityBio’s Board of Directors is available on the Directors section of this website.

When is ImmunityBio’s fiscal year end?

December 31st

On which exchange is ImmunityBio traded and what is the ticker symbol?

ImmunityBio's common stock is traded under the ticker symbol [IBRX] on The NASDAQ Global Select Market. 

How can I purchase shares of ImmunityBio?

Shares can be purchased through a stockbroker of your choice. ImmunityBio does not have a direct stock purchase program.

What is the CUSIP number for ImmunityBio’s common stock?

The CUSIP number is 45256X103.

Who is ImmunityBio’s independent registered accounting firm?

Deloitte & Touche LLP. 

Who is ImmunityBio’s transfer agent and how do I contact them?

Transfer Agent & Stockholder Services

Equiniti Trust Company, LLC

Equiniti Shareholder Services Call Center
Toll Free: 800.937.5449
Local & International: 718-921-8124
Hours: 8 a.m. – 8 p.m. ET Monday-Friday

Equiniti Trust Company, LLC
ATTN: EQ-Automated Scanning Team
1110 Centre Point Curve, Suite 101
Mendota Heights, MN 55120-4100
Email
Website

How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?

Transfer Agent & Stockholder Services

Equiniti Trust Company, LLC

Equiniti Shareholder Services Call Center
Toll Free: 800.937.5449
Local & International: 718-921-8124
Hours: 8 a.m. – 8 p.m. ET Monday-Friday

Equiniti Trust Company, LLC
ATTN: EQ-Automated Scanning Team
1110 Centre Point Curve, Suite 101
Mendota Heights, MN 55120-4100
Email
Website

Does ImmunityBio pay dividends?

We have never paid cash dividends on our common stock and do not anticipate paying cash dividends on our common stock for the foreseeable future. The payment of dividends on our common stock will depend on earnings, financial condition, restrictive covenants under our financing arrangements, including our revenue interest liability, as applicable, and other business and economic factors affecting us at such time as the Board of Directors may consider relevant.

Where can I get the latest corporate news releases and financial reports?

Copies of ImmunityBio’s news releases are available in the Investors section of this website.

How can I get copies of ImmunityBio’s filings with the Securities & Exchange Commission (SEC)?

Copies of ImmunityBio’s filings with the SEC can be accessed through the Financial Information section of this website or directly from the SEC at www.sec.gov.

How can I sign up to receive ImmunityBio’s press releases and other company information?

You can sign up to receive ImmunityBio press releases and other company information via Email Alerts.

Who do I contact Investor Relations with questions or requests?

Please complete the Information Request form.